Loading ...

doxorubicin-incorporated cross-linked KALK peptide nanoparticles

Based on

1 Articles
2017 Most recent source

Composition

1

4-mercaptobenzyloxycarbonyl moiety-modified KLAK peptide/4-mercaptobenzyloxycarbonyl moiety-modified doxorubicin 1:0.8 mol/mol

Type Complex Compound
Formula
Role raw materials
2

8-arm-poly(ethylene glycol)-thiol

8-arm-PEG-SH
Type Polymer
Formula
Role raw materials

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
colloidal stability

More information/entries available to subscribers only.

Or, view sample content

Applications

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information/entries available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
HeLa cells

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Chemical synthesis
Source:
Starting materials
  1. cCl9c9kMA8rVAtvP7KxV
  2. 6v5Q3L
Product

doxorubicin-incorporated cross-linked KALK peptide nanoparticles

Size: not specified

Medium/Support: none

Method 2

Type: Chemical synthesis
Source:
Starting materials
  1. Mo9onNh1wWNEawvdrRxf
  2. kz4H80
Product

doxorubicin-incorporated cross-linked KALK peptide nanoparticles

Diameter: ~ 180 - ~ 200 nm

Medium/Support: none

Method 3

Type: Chemical synthesis
Source:
Starting materials
  1. 7nFUwFxLzazw2FNkNJSv
  2. ePwn4u
Product

doxorubicin-incorporated cross-linked KALK peptide nanoparticles

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial